<P><p>The portal currently contains data from the following TCGA cancer genomics studies. The table below lists the number of available samples per data type and tumor.<br><br>
<table>
	<tr>
		<th align="left">Cancer Type/Study</th>
		<th>Full cancer name</th>
		<th>aCGH</th>
		<th>Sequenced</th>
		<th>Normal mRNA</th>
		<th>Tumor mRNA</th>
		<th>Complete</th>
		<th>All</th>
	</tr>

	<tr class="rowcolor">
		<td><b>BRCA</b></td>
		<td style="text-align: left;"><b>Breast invasive carcinoma</b></td>
		<td style="text-align: center;">700</td>
		<td style="text-align: center;">522</td>
		<td style="text-align: center;">0</td>
		<td style="text-align: center;">530</td>
		<td style="text-align: center;">494</td>
		<td style="text-align: center;"><b>731</b></td>
	</tr>

	<tr>
		<td><b>COAD</b></td>
		<td style="text-align: left;"><b>Colon adenocarcinoma</b></td>
		<td style="text-align: center;"></td>
		<td style="text-align: center;"></td>
		<td style="text-align: center;">0</td>
		<td style="text-align: center;">155</td>
		<td style="text-align: center;"></td>
		<td style="text-align: center;"><b>155</b></td>
	</tr>

	<tr class="rowcolor">
		<td><b>COADREAD</b></td>
		<td style="text-align: left;"><b>Colon and Rectum adenocarcinoma</b></td>
		<td style="text-align: center;">509</td>
		<td style="text-align: center;">224</td>
		<td style="text-align: center;">0</td>
		<td style="text-align: center;">224</td>
		<td style="text-align: center;">196</td>
		<td style="text-align: center;"><b>526</b></td>
	</tr>

	<tr>
		<td><b>GBM</b></td>
		<td style="text-align: left;"><b>Glioblastoma multiforme</b></td>
		<td style="text-align: center;">492</td>
		<td style="text-align: center;">372</td>
		<td style="text-align: center;">0</td>
		<td style="text-align: center;">500</td>
		<td style="text-align: center;">319</td>
		<td style="text-align: center;"><b>541</b></td>
	</tr>

	<tr class="rowcolor">
		<td><b>HNSC</b></td>
		<td style="text-align: left;"><b>Head and Neck squamous cell carcinoma</b></td>
		<td style="text-align: center;">124</td>
		<td style="text-align: center;"></td>
		<td style="text-align: center;"></td>
		<td style="text-align: center;"></td>
		<td style="text-align: center;"></td>
		<td style="text-align: center;"><b>124</b></td>
	</tr>

	<tr>
		<td><b>KIRC</b></td>
		<td style="text-align: left;"><b>Kidney renal clear cell carcinoma</b></td>
		<td style="text-align: center;">489</td>
		<td style="text-align: center;"></td>
		<td style="text-align: center;">0</td>
		<td style="text-align: center;">72</td>
		<td style="text-align: center;"></td>
		<td style="text-align: center;"><b>492</b></td>
	</tr>

	<tr class="rowcolor">
		<td><b>KIRP</b></td>
		<td style="text-align: left;"><b>Kidney renal papillary cell carcinoma</b></td>
		<td style="text-align: center;"></td>
		<td style="text-align: center;"></td>
		<td style="text-align: center;">0</td>
		<td style="text-align: center;">21</td>
		<td style="text-align: center;"></td>
		<td style="text-align: center;"><b>21</b></td>
	</tr>

	<tr>
		<td><b>LUAD</b></td>
		<td style="text-align: left;"><b>Lung adenocarcinoma</b></td>
		<td style="text-align: center;">154</td>
		<td style="text-align: center;">120</td>
		<td style="text-align: center;">0</td>
		<td style="text-align: center;">33</td>
		<td style="text-align: center;">26</td>
		<td style="text-align: center;"><b>216</b></td>
	</tr>

	<tr class="rowcolor">
		<td><b>LUSC</b></td>
		<td style="text-align: left;"><b>Lung squamous cell carcinoma</b></td>
		<td style="text-align: center;">183</td>
		<td style="text-align: center;">196</td>
		<td style="text-align: center;">0</td>
		<td style="text-align: center;">148</td>
		<td style="text-align: center;">115</td>
		<td style="text-align: center;"><b>213</b></td>
	</tr>

	<tr>
		<td><b>OV</b></td>
		<td style="text-align: left;"><b>Ovarian serous cystadenocarcinoma</b></td>
		<td style="text-align: center;">501</td>
		<td style="text-align: center;">316</td>
		<td style="text-align: center;">0</td>
		<td style="text-align: center;">538</td>
		<td style="text-align: center;">310</td>
		<td style="text-align: center;"><b>558</b></td>
	</tr>

	<tr class="rowcolor">
		<td><b>READ</b></td>
		<td style="text-align: left;"><b>Rectum adenocarcinoma</b></td>
		<td style="text-align: center;"></td>
		<td style="text-align: center;"></td>
		<td style="text-align: center;">0</td>
		<td style="text-align: center;">69</td>
		<td style="text-align: center;"></td>
		<td style="text-align: center;"><b>69</b></td>
	</tr>

	<tr>
		<td><b>STAD</b></td>
		<td style="text-align: left;"><b>Stomach adenocarcinoma</b></td>
		<td style="text-align: center;">143</td>
		<td style="text-align: center;"></td>
		<td style="text-align: center;"></td>
		<td style="text-align: center;"></td>
		<td style="text-align: center;"></td>
		<td style="text-align: center;"><b>143</b></td>
	</tr>

	<tr class="rowcolor">
		<td><b>UCEC</b></td>
		<td style="text-align: left;"><b>Uterine Corpus Endometrioid Carcinoma</b></td>
		<td style="text-align: center;">268</td>
		<td style="text-align: center;">237</td>
		<td style="text-align: center;">0</td>
		<td style="text-align: center;">44</td>
		<td style="text-align: center;">43</td>
		<td style="text-align: center;"><b>321</b></td>
	</tr>

</table>Based on the Firehose run from 09/21/2011.</p>